Articles On Avita Medical (ASX:AVH)

The Avita (ASX: AVH) share price is down more than 1% after providing an update for FY20. What is Avita? Avita is a regenerative medicine company. It aims to address unmet medical needs in burns, chronic wounds and aesthetics indications. I...

The AVITA Therapeutics Inc (ASX: AVH) share price will be on watch on Friday after the release of its fourth quarter update. How did AVITA perform in the fourth quarter? For the fourth quarter of FY 2020, the regenerative medicine company...

Australia is an amazingly innovative country – from the medical application of penicillin, the invention of WiFi, right through to the cochlear implant or bionic ear. Heck, Australia was even the birthing ground for what would become Googl...

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) looks set to start the new financial year on a positive note. At the time of writing the benchmark index is up 0.9% to 5,949.1 points. Four shares that have failed to follow the...

After redomiciling to the United States yesterday, the Avita Therapeutics Inc (ASX: AVH) share price is up 8.4% today. Avita Medical’s ordinary shares were transferred to Avita Therapeutics, based out of the US state of Delaware, via a sc...

The S&P/ASX 200 Index (ASX: XJO) rose by 0.1% to 5,943 points today. It was retail that dominated the headlines. According to the stats produced by the Australian Bureau of Statistics (ABS), Australian retail sales surged 16.3% in May...

Allied health group Advent Health is preparing to join the ranks of the ASX by way of a reverse takeover next month with a plan to improve efficiencies and boost profitability of its founding practices. The move entails shell company Mill...

The journey of each individual medical treatment from idea to market requires the involvement of multiple parties big and small. The general consensus seems to be that it takes a big player to get a drug to market, which more often than not...

The bulls are back following a massive almost 40 per cent upwards run over the last 50 days, but bearish investors are holding on to a range of theories as to why the worst is yet to come. Since the March 23 low, stocks have run harder than...

In the past fortnight there were over 30 directors trades of $100,000 or more among ASX small cap directors. The list included multiple groups of directors. Five directors from water treatment stock Phoslock (ASX:PET) put in $1.3m between t...

Morningstar believes there are some real bargain stocks to be found on the ASX. It has just released its monthly ‘Best Stock Ideas’ report highlighting companies trading at discounts to its assessed fair values. Three of them were small cap...

Due to the favourable tailwinds that it is experiencing, I believe the healthcare sector is a great place to invest with a long term view. But with so many options for investors to choose from, which ones should you be buying? Below are th...

02 Jun 2020 - AVITA Medical (ASX:AVH) has submitted an Investigational Device Exemption (IDE) supplement with the US Food and Drug Administration (FDA) for a clinical trial to inve…

Around 12 months ago, we noted that Avita Medical (AVH) – which provides a novel approach to skin regeneration – was a business worth keeping tabs on.  Although its share price has felt the effects of the COVID-19 market sell-off, our posit...

Last year was a solid year for many ASX stocks and 2020 was also looking pretty good until COVID-19 struck the markets in late February. Earlier this week Reuben Adams recapped which of last year’s top mining and exploration companies have...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

The S&P/ASX 200 Index (ASX: XJO) ended the day up 0.35% to 5,422 points. The ASX 200 was down over 1% earlier in the day. China and Australia’s dispute continues to grow. The Asian superpower reminded Australia how important it is to t...

The S&P/ASX 200 Index (ASX: XJO) was back on form in April and had its best month in decades. Over the period the benchmark index recorded a gain of 8.8%. Not all shares were able to follow the market higher last month. Here’s why thes...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Avita Medical Ltd (ASX: AVH) shares are down 2.17% in morning trade, despite the ASX healthcare company reporting strong third quarter results today.  Avita Medical reported total product sales of $5.9 million during the March quarter, up...

The S&P/ASX 200 Index (ASX: XJO) is on course to record a very strong gain on Wednesday. In late morning trade the benchmark index is up 1.2% to 5,376.4 points. Four shares that have failed to follow the market higher today are listed...

With the Avita Medical Ltd (ASX:AVH) share price sitting at 45 cents at time of writing, let’s take a quick look at this stock that lit up the ASX prior to the onset of the coronavirus. Avita recently announced a plan to relocate from Austr...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and dropped lower. At the time of writing the benchmark index is down 1.3% to 5,157.9 points. Four shares that are not letting that hold them...

Noxopharm (ASX:NOX) is the latest biotech to announce it will test its drug against COVID-19. So how exactly does an anti-prostate cancer drug work for COVID-19? Noxopharm says it is all about one signalling pathway — the STING (Stimulator...

Regenerative medicine company AVITA Medical (ASX:AVH) has announced its intention to redomicile from Australia to the US.

With the S&P/ASX 200 down as much as 130 points on Wednesday morning and a large percentage of Monday’s substantial rebound now lost, it may pay to scour the market for pockets of value. While also succumbing to the downturn in the broa...

With the S&P/ASX 200 down as much as 130 points on Wednesday morning and a large percentage of Monday’s substantial rebound now lost, it may pay to scour the market for pockets of value. While also succumbing to the downturn in the broa...

Alcidion’s (ASX:ALC) market cap may suggest it’s still a small cap, but it has come a long way from its founding and reverse IPO in 2016. The company is now larger than all 11 other ASX medtechs it listed in its investor presentation as com...

The healthcare sector has been one of the top-performing ASX industry sectors during the coronavirus crisis. This is only likely to continue over the next 6 months due to a high and continuing demand for a range of healthcare products and...

ASX shares are trading at deep discounts from previous highs thanks to the coronavirus pandemic. This gives investors the chance to swoop in on some bargains. So, let’s take a look at 5 ASX shares to buy across the technology and healthca...

The Ramsay Health Care Limited (ASX: RHC) share price is back on form on Thursday. On Wednesday Ramsay’s shares fell heavily after the government announced that it would soon stop elective surgeries. But in afternoon trade the private hosp...

Yesterday I highlighted a number of factors that could be seen as justification for investing in more speculative stocks in the current environment. Though seemingly counter-intuitive given the broader flight from equities to safe havens su...

In just two years, skin regenerator Avita Medical (ASX:AVH) has shot up from 6c to 40c and was granted entry into the ASX 200, but the company says it hasn’t made it yet. Chief financial officer David McIntyre, who joined Avita in November...

The ASX healthcare sector continues to be one of the top performers on the ASX in terms of share price rises. While most Australians are likely familiar with Cochlear Limited (ASX: COH), CSL Limited (ASX: CSL), and Ramsay Health Care Limit...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

Australian investors enter the weekend with the ASX 200 (INDEXASX: XJO) falling over 2% on the final day of the week. How much did the ASX 200 fall over this week? Well it finished down 2.8% today to 6,216, which was a fall of 3.5% during...

The S&P/ASX 200 index has given back yesterday’s gains and more. In afternoon trade the benchmark index is down 1.8% to 6,281.3 points. Four shares that have fallen more than most today are listed below. Here’s why they are tumbling lo...

Shares in ASX 200 healthcare group Avita Medical Ltd (ASX: AVH) have had an impressive run in the last 12 months. In the past year, the medical tech group’s shares are up 353.57% higher to $0.64 per share. That means Avita’s market capital...

Regenerative medicine company Avita Medical (ASX: AVH) has commenced what it calls a “pivotal trial” for the treatment of paediatric scald injuries, seeking to demonstrate that its RECELL treatment can safely and effectively increase the in...

The S&P/ASX 200 index has followed the lead of U.S. markets and is charging higher on Thursday. At the time of writing the benchmark index is up 1.5% to 6,423.1 points. Four shares that are climbing more than most today are listed belo...

Regenerative medicine company AVITA Medical (ASX:AVH) has announced the initiation of a trial for the treatment of paediatric scald injuries with an enrollment of the first patient in the US.

In morning trade the AVITA Medical Ltd (ASX: AVH) share price has been storming higher. At the time of writing the regenerative medicine company’s shares are up 7% to 66.5 cents. Why is the AVITA Medical share price storming higher? As wel...

In early afternoon trade the S&P/ASX 200 index is trading notably lower. At the time of writing the benchmark index is down 1.2% to 6,357.2 points. Four shares that have not let that hold them back are listed below. Here’s why they are...

Bone healing biotech company Osteopore (ASX: OSX) has posted strong revenue growth since its ASX debut, eyeing China and the US as the next markets for its regenerative technology. The Australian and Singapore-based business listed on the...

Whilst today’s market selloff is disappointing, it is worth remembering that even after today’s sea of red, the share market is still up significantly over the last 12 months. For example, since this time last year, the S&P/ASX 200 ind...

By Michael Gable  Despite the coronavirus, the US share market has made another all-time high, and the Australian market has been consolidating the gains from early January in an orderly fashion. Materials and Energy stocks remain a bit ris...

While the S&P/ASX 200 Index (INDEXASX: XJO) ended the day slightly down, here are 3 ASX shares that have shown strong upward share price movement today. AVITA Medical Ltd (ASX: AVH) After rocketing as much as 7.5% in mid-afternoon tr...

Spray-on-skin maker Avita has had runaway success on the ASX. And it's not done yet, says Morningstar's Nicolette Quinn.

The Polynovo Ltd (ASX: PNV) share price has been on a tear this year, up more than 56% so far. In December, sales of the company’s NovoSorb BTM product cracked $2 million for the first time, a 134% increase over the previous December. Nov...

By Greg Peel Second Leg Wall Street had used the excuse of solid earnings results and a better than expected GDP performance to turn around an initial fall on Thursday night into a rally on the close. Traders were not letting coronavi...